Skip to main content
Mohamed Sorror, MD, Oncology, Seattle, WA, Fred Hutchinson Cancer Center

MohamedLSorrorMD

Oncology Seattle, WA

Hematologic Oncology

Assistant Professor, Medicine, University of Washington School of Medicine

Dr. Sorror is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sorror's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
  • University of Assiut Faculty of Medicine
    University of Assiut Faculty of MedicineClass of 1993

Certifications & Licensure

  • MT State Medical License
    MT State Medical License 2022 - 2024
  • WA State Medical License
    WA State Medical License 2005 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pre-Transplant Expressions of microRNAs, Comorbidities, and Post-Transplant Mortality  
    Mohamed L Sorror, Muneesh Tewari, Nature

Abstracts/Posters

  • Frequency, and Effect on Survival, of Ineligibility for Clinical Trials in Newly Diagnosed Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
    Mohamed L. Sorror, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, More
    Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
  • Age No Longer a Barrier to Stem Cell Transplantation for Older Patients
    Age No Longer a Barrier to Stem Cell Transplantation for Older PatientsNovember 2nd, 2011
  • Use of Low-Toxicity Conditioning Regimen Prior to Cell Transplantation Appears Promising for Older Adults with Blood, Bone Marrow Cancers
    Use of Low-Toxicity Conditioning Regimen Prior to Cell Transplantation Appears Promising for Older Adults with Blood, Bone Marrow CancersNovember 1st, 2011

Grant Support

  • Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2011–2012
  • Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2007–2008

Hospital Affiliations